ATE294173T1 - 1-(2-naphthyl) und 1-(2-azanaphthyl)-4-(1- phenylmethyl)piperazine als dopamin d4 subtype liganden - Google Patents
1-(2-naphthyl) und 1-(2-azanaphthyl)-4-(1- phenylmethyl)piperazine als dopamin d4 subtype ligandenInfo
- Publication number
- ATE294173T1 ATE294173T1 AT98952391T AT98952391T ATE294173T1 AT E294173 T1 ATE294173 T1 AT E294173T1 AT 98952391 T AT98952391 T AT 98952391T AT 98952391 T AT98952391 T AT 98952391T AT E294173 T1 ATE294173 T1 AT E294173T1
- Authority
- AT
- Austria
- Prior art keywords
- azanaphthyl
- phenylmethyl
- dopamine
- piperazine
- naphthyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/78—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 2
- C07D239/84—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/36—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
- C07D241/38—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with only hydrogen or carbon atoms directly attached to the ring nitrogen atoms
- C07D241/40—Benzopyrazines
- C07D241/44—Benzopyrazines with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/06—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals
- C07D295/073—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals with the ring nitrogen atoms and the substituents separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US95435397A | 1997-10-24 | 1997-10-24 | |
| PCT/US1998/022233 WO1999021850A1 (en) | 1997-10-24 | 1998-10-21 | 1-(2-naphthyl) and 1-(2-azanaphthyl)-4-(1-phenylmethyl)piperazines being dopamine d4 receptor subtype ligands |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE294173T1 true ATE294173T1 (de) | 2005-05-15 |
Family
ID=25495312
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT98952391T ATE294173T1 (de) | 1997-10-24 | 1998-10-21 | 1-(2-naphthyl) und 1-(2-azanaphthyl)-4-(1- phenylmethyl)piperazine als dopamin d4 subtype liganden |
Country Status (11)
| Country | Link |
|---|---|
| EP (1) | EP1025097B1 (de) |
| CN (1) | CN1191248C (de) |
| AR (1) | AR015983A1 (de) |
| AT (1) | ATE294173T1 (de) |
| AU (1) | AU9810498A (de) |
| CA (1) | CA2308057A1 (de) |
| CO (1) | CO4970840A1 (de) |
| DE (1) | DE69829989T2 (de) |
| ES (1) | ES2241172T3 (de) |
| WO (1) | WO1999021850A1 (de) |
| ZA (1) | ZA989720B (de) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6040448A (en) * | 1997-10-24 | 2000-03-21 | Neurogen Corporation | Certain 1-(2-naphthyl) and 1-(2-azanaphthyl)-4-(1-phenylmethyl) piperazines, dopamine receptor subtype specific ligands |
| AU6242999A (en) * | 1998-09-02 | 2000-03-21 | Neurogen Corporation | 2-aryl-4-(1-(4-heteroaryl)piperazin-1-yl) methylimidazoles: dopamine d4 receptor subtype ligands |
| EP1177792A3 (de) | 2000-07-27 | 2002-10-23 | Pfizer Products Inc. | Dopamin-d4-ligande zur behandlung von gaudi-suchenden krankheiten |
| PE20060115A1 (es) | 2004-07-23 | 2006-03-23 | Basf Ag | 2-(piridin-2-il)-pirimidinas como agentes fungicidas |
| BRPI0609268A2 (pt) | 2005-03-31 | 2010-03-09 | Pfizer Prod Inc | derivados de ciclopentapiridina e tetraidroquinolina |
| JP4769866B2 (ja) | 2005-06-27 | 2011-09-07 | エフ．ホフマン−ラ ロシュ アーゲー | クロロ置換グアニジン |
| CN103992270B (zh) * | 2014-05-13 | 2016-06-08 | 泸州医学院 | 2-氯-5,6,7,8-四氢喹啉的制备方法 |
| EP3868752A1 (de) | 2014-08-28 | 2021-08-25 | Asceneuron SA | Glycosidase-inhibitoren |
| US11261183B2 (en) | 2016-02-25 | 2022-03-01 | Asceneuron Sa | Sulfoximine glycosidase inhibitors |
| EP3419972B1 (de) | 2016-02-25 | 2023-07-26 | Asceneuron SA | Glycosidase-inhibitoren |
| MA43677A (fr) | 2016-02-25 | 2018-11-28 | Asceneuron Sa | Inhibiteurs de glycosidases |
| CN109071526B (zh) | 2016-02-25 | 2023-02-28 | 阿森纽荣股份公司 | 哌嗪衍生物的酸加成盐 |
| SG11201907774VA (en) | 2017-02-24 | 2019-09-27 | Asceneuron S A | Sulfoximine glycosidase inhibitors |
| WO2019037861A1 (en) | 2017-08-24 | 2019-02-28 | Asceneuron S.A. | ANNOTATED GLYCOSIDASE INHIBITORS |
| EP3672959A1 (de) | 2017-08-24 | 2020-07-01 | Asceneuron SA | Lineare glycosidase-inhibitoren |
| WO2020039027A1 (en) | 2018-08-22 | 2020-02-27 | Asceneuron S. A. | Pyrrolidine glycosidase inhibitors |
| US11731972B2 (en) | 2018-08-22 | 2023-08-22 | Asceneuron Sa | Spiro compounds as glycosidase inhibitors |
| WO2020039028A1 (en) | 2018-08-22 | 2020-02-27 | Asceneuron S. A. | Tetrahydro-benzoazepine glycosidase inhibitors |
| WO2020169804A1 (en) | 2019-02-22 | 2020-08-27 | Asceneuron Sa | Fused glycosidase inhibitors |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3576809A (en) * | 1968-05-06 | 1971-04-27 | Miles Lab | 2-substituted derivatives of 6-methoxyquinoline |
| US3629418A (en) * | 1969-02-14 | 1971-12-21 | Miles Lab | Process for producing an anti-depressant effect with piperazine quinolines |
| FI193974A (de) * | 1973-07-13 | 1975-01-14 | Merck & Co Inc | |
| US4091098A (en) * | 1977-04-25 | 1978-05-23 | Merck & Co., Inc. | 3-(1-PIPERAZINYL)-1,2,4-BENZOTRIAZINES AND N-oxides |
| DE2811312A1 (de) * | 1978-03-16 | 1979-09-27 | Hoechst Ag | Neue isochinolinderivate, verfahren zu ihrer herstellung und ihre verwendung zur herstellung von arzneimitteln |
| FR2692264B1 (fr) * | 1992-06-12 | 1994-08-05 | Adir | Nouvelles piperazines 1,4-disubstituees, leur procede de preparation et les compositions pharmaceutiques les contenant. |
| FR2734819B1 (fr) * | 1995-05-31 | 1997-07-04 | Adir | Nouveaux composes de la piperazine, de la piperidine et de la 1,2,5,6-tetrahydropyridine, leur procede de preparation et les compositions pharmaceutiques les contenant |
| US5859246A (en) * | 1997-01-30 | 1999-01-12 | Neurogen Corporation | 1-phenyl-4-benzylpiperazines: dopamine receptor subtype specific ligands |
| NZ337183A (en) * | 1997-03-04 | 2001-05-25 | Neurogen Corp | 1-(isoquinolin-1-yl)-4-(1-phenylmethyl)piperazines; dopamine receptor subtype specific ligands useful for the treatment of psychotic disorders |
-
1998
- 1998-10-21 EP EP98952391A patent/EP1025097B1/de not_active Expired - Lifetime
- 1998-10-21 DE DE69829989T patent/DE69829989T2/de not_active Expired - Fee Related
- 1998-10-21 WO PCT/US1998/022233 patent/WO1999021850A1/en active IP Right Grant
- 1998-10-21 AT AT98952391T patent/ATE294173T1/de not_active IP Right Cessation
- 1998-10-21 CN CNB988126583A patent/CN1191248C/zh not_active Expired - Fee Related
- 1998-10-21 AU AU98104/98A patent/AU9810498A/en not_active Abandoned
- 1998-10-21 ES ES98952391T patent/ES2241172T3/es not_active Expired - Lifetime
- 1998-10-21 CA CA002308057A patent/CA2308057A1/en not_active Abandoned
- 1998-10-26 AR ARP980105336A patent/AR015983A1/es unknown
- 1998-10-26 CO CO98062496A patent/CO4970840A1/es unknown
- 1998-10-26 ZA ZA989720A patent/ZA989720B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP1025097A1 (de) | 2000-08-09 |
| CN1283195A (zh) | 2001-02-07 |
| CA2308057A1 (en) | 1999-05-06 |
| EP1025097B1 (de) | 2005-04-27 |
| DE69829989D1 (en) | 2005-06-02 |
| ZA989720B (en) | 1999-04-26 |
| CN1191248C (zh) | 2005-03-02 |
| WO1999021850A1 (en) | 1999-05-06 |
| ES2241172T3 (es) | 2005-10-16 |
| DE69829989T2 (de) | 2006-02-23 |
| AU9810498A (en) | 1999-05-17 |
| CO4970840A1 (es) | 2000-11-07 |
| AR015983A1 (es) | 2001-05-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE294173T1 (de) | 1-(2-naphthyl) und 1-(2-azanaphthyl)-4-(1- phenylmethyl)piperazine als dopamin d4 subtype liganden | |
| DE60127997D1 (de) | 1,5-benzothiazepine und ihre verwendung als antihyperlipidämika | |
| PL353446A1 (en) | N-(indolcarbonyl-)piperazin derivatives als 5-ht2a-receptor ligands | |
| DE69929983D1 (de) | Trifluoromethylpyrrolcarboxamide und ihre anwendung als fungizide | |
| DE60111540D1 (de) | Tetrazolylphenyl-acetamide als glukokinaseaktivatoren | |
| DE60006580D1 (de) | Benzazolderivate und ihre verwendung als jnk modulatoren | |
| ATE370931T1 (de) | Heterozyklische verbindungen und ihre verwendungen | |
| NO20031161D0 (no) | Chemokin-reseptorbindende heterocykliske forbindelser | |
| DE60031513D1 (de) | Phenyl- und pyridinyl-derivate verwendbar als neurokinin-1-antagonisten | |
| MX9906600A (es) | 4-(3-heterociclil-1-benzoil)pirazoles | |
| DE69524925T2 (de) | Pyrazinone und ihre Verwendung als Fungizide | |
| ATE357432T1 (de) | Substituierte 2-amino-zykloalkankarboxamide und ihre verwendung als zysteinprotease-inhibitoren | |
| DE69907754D1 (de) | Filterträger,filterträgeranordnung und system | |
| DE60038911D1 (de) | 4-Phenylpiperazinyl, -piperidinyl und -tetrahydropyridyl-Derivate als Dopamin D4-Antagonisten | |
| SE0102384D0 (sv) | New compounds | |
| ATE268327T1 (de) | Benzazol-verbindungen und ihre verwendung | |
| DE60231784D1 (de) | Überbrückungs-Chipbauteil und Montierungsanordnung dafür | |
| DE69929797D1 (de) | Staubfilterstoff und filterbeutel | |
| DE50009976D1 (de) | Kolbenmaschine und Verteilelement | |
| DE50108402D1 (de) | N-alkoxyalkyl-substituierte benzimidazole und ihre verwendung als mittel gegen parasitäre protozoen | |
| HUP0001391A3 (en) | 1-(isoquinolin-1-yl)-4-(1-phenylmethyl) piperazines, dopamine receptor subtype specific ligands | |
| DE60023362D1 (de) | Isochinolincarboxamide und ihre Verwendung als anticonvulsiva | |
| LU90601B1 (de) | Einrichtung zum Entwachsen von Sintermaterial | |
| ATE347544T1 (de) | Substituierte phenylcyclohexancarbonsäureamide und ihre verwendung | |
| ITTO20000776A0 (it) | Ventilatore filtrante. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |